Last reviewed · How we verify
MEDICAL GLAUCOMA TREATMENT
At a glance
| Generic name | MEDICAL GLAUCOMA TREATMENT |
|---|---|
| Sponsor | Xerencia de Xestión Integrada de Ferrol |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Evaluation of Performance and Safety of Carbopol 980 NF 0.2%- Based Medical Device in the Management of Patients With Glaucomar or Ocular Hypertension and Concomitant Dry Eye Syndrome on Multiple Long-term Topical Hypotensive Therapy (NA)
- PRESERFLO™ MicroShunt XI Observational PMCF Study With no Control Group
- A Comparative Study of Intraocular Pressure Control Using Selective Laser Trabeculoplasty and Latanoprost as Initial Treatments for Primary Open Angle Glaucoma and Ocular Hypertension in Lagos State University Teaching Hospital (NA)
- Effect of Kron (Citicoline and Nicotinamide Oral Solution) on Patients With Open-angle Glaucoma (NA)
- Awareness and Perception of Glaucoma Among Patients Attending Ophthalmology OPD in a Tertiary Care Hospital.
- Nicotinamide Levels in Serum, Aqueous Humor, and Tear Film in Glaucoma and Correlations With Mitochondrial Damage-Associated Molecular Patterns (mtDAMPs) and Senescence-Associated Secretory Phenotype (SASP) (NA)
- A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Patients With Primary Open Angle Glaucoma (PHASE4)
- MIMS® Retrospective Chart Review
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MEDICAL GLAUCOMA TREATMENT CI brief — competitive landscape report
- MEDICAL GLAUCOMA TREATMENT updates RSS · CI watch RSS
- Xerencia de Xestión Integrada de Ferrol portfolio CI